Status:
RECRUITING
Self-Identification Program
Lead Sponsor:
University Hospital, Montpellier
Conditions:
Major Depressive Disorder
Third Wave Cognitive Behavioral Therapy
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
Conduct a pilot, single-center, randomized controlled 2-arm study aimed to evaluate the impact of an in-depth 3rd wave CBT program targeting correct self-identification (3rd level of 3rd wave CBT), co...
Detailed Description
According to the World Health Organization (WHO), depression is one of the health problems most prevalent mental health issues of the 21st century. Currently available treatments are insufficient to t...
Eligibility Criteria
Inclusion
- Patients aged 18 to 70 years, presenting a current major depressive episode (according to DSM 571), as part of unipolar or bipolar depressive disorder
Exclusion
- Patients with a psychotic disorder
- Patients with active thoughts of suicide with intention to carry out the act (C-SSRS "ideation suicidal" in the last week ≥ 4)
- Inability to receive informed information about the study
- Exclusion period determined by a previous study
- Adult protected by law or patient under guardianship or curatorship
- Not be affiliated to a French social security scheme or beneficiary of such a scheme
- Not being able to give informed written consent
- Pregnant or breastfeeding women
- Patients under judicial protection
Key Trial Info
Start Date :
August 27 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2028
Estimated Enrollment :
86 Patients enrolled
Trial Details
Trial ID
NCT06183359
Start Date
August 27 2024
End Date
February 1 2028
Last Update
September 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Montpellier
Montpellier, France